These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17114464)

  • 1. Mapping of quantitative trait loci determining NK cell-mediated resistance to MHC class I-deficient bone marrow grafts in perforin-deficient mice.
    Johansson MH; Taylor MA; Jagodic M; Tus K; Schatzle JD; Wakeland EK; Bennett M
    J Immunol; 2006 Dec; 177(11):7923-9. PubMed ID: 17114464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perforin- and Fas-dependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts.
    Taylor MA; Ward B; Schatzle JD; Bennett M
    Eur J Immunol; 2002 Mar; 32(3):793-9. PubMed ID: 11870623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional defects of NK cells treated with chloroquine mimic the lytic defects observed in perforin-deficient mice.
    Austin Taylor M; Bennett M; Kumar V; Schatzle JD
    J Immunol; 2000 Nov; 165(9):5048-53. PubMed ID: 11046034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-primed CD8+ T cells can mediate resistance, preventing allogeneic marrow engraftment in the simultaneous absence of perforin-, CD95L-, TNFR1-, and TRAIL-dependent killing.
    Komatsu M; Mammolenti M; Jones M; Jurecic R; Sayers TJ; Levy RB
    Blood; 2003 May; 101(10):3991-9. PubMed ID: 12521999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the death receptor pathway by cFLIP confers partial engraftment of MHC class I-deficient stem cells and reduces tumor clearance in perforin-deficient mice.
    Taylor MA; Chaudhary PM; Klem J; Kumar V; Schatzle JD; Bennett M
    J Immunol; 2001 Oct; 167(8):4230-7. PubMed ID: 11591744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum.
    Smyth MJ; Kelly JM; Baxter AG; Körner H; Sedgwick JD
    J Exp Med; 1998 Nov; 188(9):1611-9. PubMed ID: 9802973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NK cells rapidly reject allogeneic bone marrow in the spleen through a perforin- and Ly49D-dependent, but NKG2D-independent mechanism.
    Hamby K; Trexler A; Pearson TC; Larsen CP; Rigby MR; Kean LS
    Am J Transplant; 2007 Aug; 7(8):1884-96. PubMed ID: 17617852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
    Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
    Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ly49I NK cell receptor transgene inhibition of rejection of H2b mouse bone marrow transplants.
    Liu J; Morris MA; Nguyen P; George TC; Koulich E; Lai WC; Schatzle JD; Kumar V; Bennett M
    J Immunol; 2000 Feb; 164(4):1793-9. PubMed ID: 10657626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perforin- and Fas-mediated cytotoxic pathways are not required for allogeneic resistance to bone marrow grafts in mice.
    Baker MB; Podack ER; Levy RB
    Biol Blood Marrow Transplant; 1995 Dec; 1(2):69-73. PubMed ID: 9118294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine and cytotoxic pathways of NK cell rejection of class I-deficient bone marrow grafts: influence of mouse colony environment.
    Bennett M; Taylor PA; Austin M; Baker MB; Schook LB; Rutherford M; Kumar V; Podack ER; Mohler KM; Levy RB; Blazar BR
    Int Immunol; 1998 Jun; 10(6):785-90. PubMed ID: 9678759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perforin-dependent cytolytic responses in beta2-microglobulin-deficient mice.
    Smyth MJ; Snook MB
    Cell Immunol; 1999 Aug; 196(1):51-9. PubMed ID: 10486155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin.
    Hayakawa Y; Kelly JM; Westwood JA; Darcy PK; Diefenbach A; Raulet D; Smyth MJ
    J Immunol; 2002 Nov; 169(10):5377-81. PubMed ID: 12421908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the perforin and Fas pathways of cytotoxicity in skin graft rejection.
    Selvaggi G; Ricordi C; Podack ER; Inverardi L
    Transplantation; 1996 Dec; 62(12):1912-5. PubMed ID: 8990386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased tumor surveillance in perforin-deficient mice.
    van den Broek ME; Kägi D; Ossendorp F; Toes R; Vamvakas S; Lutz WK; Melief CJ; Zinkernagel RM; Hengartner H
    J Exp Med; 1996 Nov; 184(5):1781-90. PubMed ID: 8920866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic investigation of MHC-independent missing-self recognition by mouse NK cells using an in vivo bone marrow transplantation model.
    Chen P; Aguilar OA; Rahim MM; Allan DS; Fine JH; Kirkham CL; Ma J; Tanaka M; Tu MM; Wight A; Kartsogiannis V; Gillespie MT; Makrigiannis AP; Carlyle JR
    J Immunol; 2015 Mar; 194(6):2909-18. PubMed ID: 25681346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of perforin-independent NK cell-mediated cytotoxicity.
    Wallin RP; Screpanti V; Michaëlsson J; Grandien A; Ljunggren HG
    Eur J Immunol; 2003 Oct; 33(10):2727-35. PubMed ID: 14515256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells.
    Screpanti V; Wallin RP; Ljunggren HG; Grandien A
    J Immunol; 2001 Aug; 167(4):2068-73. PubMed ID: 11489989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cells recognize common antigenic motifs shared by H-2Dd, H-2Ld and possibly H-2Dr molecules expressed on bone marrow cells.
    Yu YY; Forman J; Aldrich C; Blazar B; Flaherty L; Kumar V; Bennett M
    Int Immunol; 1994 Sep; 6(9):1297-306. PubMed ID: 7529556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.